- Home
- LSTA
as 07-04-2025 12:34pm EST
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
| Founded: | 1980 | Country: | United States |
| Employees: | N/A | City: | BASKING RIDGE |
| Market Cap: | 24.1M | IPO Year: | N/A |
| Target Price: | $15.00 | AVG Volume (30 days): | 15.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.87 - $4.20 | Next Earning Date: | 08-11-2025 |
| Revenue: | $1,000,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Lisata Therapeutics Inc. News
LSTA Breaking Stock News: Dive into LSTA Ticker-Specific Updates for Smart Investing
MT Newswires
9 days ago
Lisata Reports Survival, Response Benefits With Certepetide in Pancreatic Cancer Trial
GlobeNewswire
10 days ago
Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer
Pharmaceutical Technology
18 days ago
Lisata collaborates with GATC Health on drug development
GlobeNewswire
19 days ago
Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development
GlobeNewswire
25 days ago
Lisata Therapeutics to Present at the 2025 BIO International Convention
GuruFocus.com
2 months ago
Lisata Therapeutics Inc (LSTA) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Market ...
GlobeNewswire
2 months ago
Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
2 months ago
Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025
Compare LSTA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LSTA Lisata Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.